<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02816697</url>
  </required_header>
  <id_info>
    <org_study_id>16-208</org_study_id>
    <nct_id>NCT02816697</nct_id>
  </id_info>
  <brief_title>Implementation of a System-level Tobacco Treatment Intervention</brief_title>
  <official_title>Implementation of a System-level Tobacco Treatment Intervention in Thoracic Oncology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dana-Farber Cancer Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study plans to adapt and study the implementation and effectiveness of
      integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the
      thoracic oncology setting using mixed methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In particular the study aims to see if participants are asked about their smoking status and
      what services are offered if someone indicates being a former or current smoker. Findings
      from this study will help improve a standard of care at this clinic and allow us to
      understand what type of tobacco treatment services are preferred by patients.

        -  Adaption of CEASE will entail exit interviews with patients and individual interviews
           with clinical staff to identify and address facilitators and barriers to the
           implementation process.

        -  Effectiveness of CEASE will be measured through questionnaires &amp; biochemical
           verification of smoking status using a pre-test/post-test study design before (usual
           care)and after implementation (CEASE)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Smoking cessation Rate</measure>
    <time_frame>6 Months</time_frame>
    <description>Biochemical verification of smoking cessation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Documentation of tobacco treatment</measure>
    <time_frame>2 months after CEASE</time_frame>
    <description>Assess documentation of smoking assessment and provision of treatment ( medication and referral for behavioral counseling)</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Smoking Cessation</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Cease-Aim 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cease Implementation
100 Patients after CEASE Implementation
Exit Interview and Tobacco Use Survey</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre Cease Implementation Aim 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 Current or former smokers (3 months +/-2 month) patients in usual care (before CEASE implementation)
Tobacco Use Survey (Baseline,1- 6 Months)
Biochemical verification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>After Cease Implementation Aim 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 Current or former smokers (3 months +/-2 month)
Tobacco Use Survey (Baseline,1- 6 Months)
Biochemical verification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care-Aim 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual Care Tobacco Treatment Services
100 patients in usual care
Exit Interview and Tobacco Use Survey</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinician and Staff Survey</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>- Interview clinicians and support staff (40)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CEASE</intervention_name>
    <description>Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE)
CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits</description>
    <arm_group_label>Cease-Aim 1</arm_group_label>
    <arm_group_label>After Cease Implementation Aim 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care Tobacco Treatment Services</intervention_name>
    <arm_group_label>Pre Cease Implementation Aim 2</arm_group_label>
    <arm_group_label>Usual Care-Aim 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18

          -  Have an actual or potential diagnosis of thoracic malignancy

          -  Able to read and write in English.

          -  Current or recent former smoker (defined as having smoked within past 6 months)

          -  Must have an active telephone number.

        Exclusion Criteria:

          -  Former smoker greater than 6 months.

          -  Have any of the below conditions needing immediate medical intervention

               -  Hypercalcemia causing lethargy and confusion,

               -  Acute respiratory distress

               -  Dehydration

               -  Hypotension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary E Cooley, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dana-Farber Cancer Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mary E Cooley, PhD, RN</last_name>
    <phone>617-632-5096</phone>
    <email>mary_cooley@dfci.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael Bueno, MD</last_name>
      <phone>617-732-8148</phone>
      <email>rbueno@partners.org</email>
    </contact>
    <investigator>
      <last_name>Raphael Bueno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary E Cooley, MD</last_name>
      <phone>617-632-5096</phone>
    </contact>
    <investigator>
      <last_name>Mary E Cooley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>October 19, 2016</last_update_submitted>
  <last_update_submitted_qc>October 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dana-Farber Cancer Institute</investigator_affiliation>
    <investigator_full_name>Mary E. Cooley, Phd</investigator_full_name>
    <investigator_title>Mary E. Cooley MD</investigator_title>
  </responsible_party>
  <keyword>Smoking Habits</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

